92. MacKie RM, Hole D. Audit of public education campaign to encourage earlier detection of malignant melanoma. BMJ 1992; 304:1012–1015.
93. Giles GG, Armstrong BK, Burton RC, Staples MP, Thursfield VJ. Has mortality from melanoma stopped rising in Australia? Analysis of trends between 1931 and 1994. BMJ 1996; 312:1121–1125.
94. Melia J, Cooper EJ, Frost T, et al. Cancer Research Campaign health education programme to promote the early detection of cutaneous malignant melanoma. II. Characteristics and incidence of melanoma. Br J Dermatol 1995; 132:414–421.
95. Melia J. Early detection of cutaneous malignant melanoma in Britain. Int J Epidemiol 1995; 24:S39–44.
96. Metzger S, Ellwanger U, Stroebel W, Schiebel U, Rassner G, Fierlbeck G. Extent and consequences of physician delay in the diagnosis of acral melanoma. Melanoma Res 1998; 8:181–186.
97. Warso M, Gray T, Gonzalez M. Melanoma of the hand. J Hand Surg 1997; 22:354–360.
98. Larsson K, Shaw H, Thompson J, Harman R, McCarthy W. Primary mucosal and glans penis melanomas: The Sydney Melanoma Unit experience. Aust NZ J Surg 1999; 69:121–126.
99. Holden R, Damato B. Preventable delays in the treatment of intraocular melanoma in the UK. Eye 1996; 10:127–129.
100. Bennett DR, Wasson D, MacArthur JD, McMillen MA. The effect of misdiagnosis and delay in diagnosis on clinical outcome in melanomas of the foot. J Am Coll Surg 1994; 179:279–284.
101. Baccard M, Chevret S, Chemaly P, Morel P. Delay in diagnosing melanoma. A prospective study in 102 patients. Annal Dermatol Venereol 1997; 124:601–606.
102. Epstein DS, Lange JR, Gruber SB, Mofid M, Koch SE. Is physician detection associated with thinner melanomas? JAMA 1999; 281:640–643.
103. Richard MA, Grob JJ, Avril MF, et al. Melanoma and tumor thickness: Challenges of early diagnosis. Arch Dermatol 1999; 135:269–274.
104. Freedberg K. Screening for melanoma: A cost-effectiveness analysis. J Am Acad Dermatol 1999; 41:738–745.